MedPath

Sodium Citrate

Anticoagulant Sodium Citrate Solution, USP

Approved
Approval ID

1a2ad203-63fe-42ac-88c6-23dd28385005

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 9, 2015

Manufacturers
FDA

Haemonetics Manufacturing Inc

DUNS: 078598396

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Anticoagulant Sodium Citrate Solution

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53157-798
Application NumberNDA760305
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Sodium Citrate Solution
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 9, 2015
FDA Product Classification

INGREDIENTS (1)

SODIUM CITRATEActive
Quantity: 10.0 g in 250 mL
Code: 1Q73Q2JULR
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sodium Citrate - FDA Drug Approval Details